In the rapidly evolving realm of advanced therapy medicinal products (ATMPs) and complex biologics, the promise of transforming patient care is both exhilarating and daunting, as these cutting-edge treatments hold the potential to address some of the most pressing unmet medical needs, from rare
In a quiet corner of Devon, UK, Jason Yeo, a 54-year-old father of two and a traveling sales manager, faced a challenge he never saw coming—a prostate cancer diagnosis in April 2024 that could have easily slipped under the radar. With no prior health issues or noticeable symptoms, his story serves
The recent federal government shutdown, which began on October 1, has sent ripples through the healthcare sector, creating significant disruptions for both providers and patients reliant on Medicare services. This unexpected halt in government operations has led to immediate holds on Durable
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in technology and innovation within the industry. With a strong background in research and development, Ivan brings a unique perspective on the integration of artificial intelligence in healthcare.
In an era where telehealth services have become a lifeline for many seeking convenient medical solutions, a troubling trend has emerged in the marketing of weight-loss drugs, particularly compounded GLP-1 medications. A staggering 1,200 percent increase in questionable advertisements since just a
The healthcare sector in the United States is at a critical juncture as private equity (PE) firms tighten their grip on hospitals, igniting fierce debate over the consequences for patient care and raising serious concerns about the balance between profit and well-being. With over $1 trillion
